Considering the association of these two endocrine tumors, the patient received a clinical diagnosis of MEN1 and underwent surgical resection of the insulinoma and drug treatment of the prolactinoma with cabergoline at a dose of 0.75 mg/week. Here, MEN1 is linked to pancreatic insulinoma.